222 related articles for article (PubMed ID: 19647240)
1. Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management.
Das A; Ngamruengphong S; Nagendra S; Chak A
Gastrointest Endosc; 2009 Oct; 70(4):690-699.e6. PubMed ID: 19647240
[TBL] [Abstract][Full Text] [Related]
2. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.
Das A; Singh P; Sivak MV; Chak A
Gastrointest Endosc; 2007 Jun; 65(7):960-8. PubMed ID: 17331513
[TBL] [Abstract][Full Text] [Related]
4. A cost-minimization analysis of alternative strategies in diagnosing pancreatic cancer.
Chen VK; Arguedas MR; Kilgore ML; Eloubeidi MA
Am J Gastroenterol; 2004 Nov; 99(11):2223-34. PubMed ID: 15555006
[TBL] [Abstract][Full Text] [Related]
5. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis.
Arguedas MR; Heudebert GH; Stinnett AA; Wilcox CM
Am J Gastroenterol; 2002 Apr; 97(4):898-904. PubMed ID: 12003425
[TBL] [Abstract][Full Text] [Related]
6. How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? A cost-effectiveness analysis.
Zanocco K; Sturgeon C
Surgery; 2008 Aug; 144(2):290-8. PubMed ID: 18656638
[TBL] [Abstract][Full Text] [Related]
7. Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years.
Goh BK; Tan YM; Cheow PC; Chung YF; Chow PK; Wong WK; Ooi LL
Am J Surg; 2006 Aug; 192(2):148-54. PubMed ID: 16860621
[TBL] [Abstract][Full Text] [Related]
8. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
10. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of endarterectomy in patients with asymptomatic carotid artery stenosis.
Henriksson M; Lundgren F; Carlsson P
Br J Surg; 2008 Jun; 95(6):714-20. PubMed ID: 18412295
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic pancreatic cysts: a decision analysis approach to observation versus resection.
Liao T; Velanovich V
Pancreas; 2007 Oct; 35(3):243-8. PubMed ID: 17895845
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Kwon JS; Lu KH
Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
[TBL] [Abstract][Full Text] [Related]
14. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of repeat fine-needle aspiration for thyroid biopsies read as atypia of undetermined significance.
Heller M; Zanocco K; Zydowicz S; Elaraj D; Nayar R; Sturgeon C
Surgery; 2012 Sep; 152(3):423-30. PubMed ID: 22938902
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD.
Oba Y
Am J Manag Care; 2009 Apr; 15(4):226-32. PubMed ID: 19355795
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model.
Fiddelers AA; Dirksen CD; Dumoulin JC; van Montfoort AP; Land JA; Janssen JM; Evers JL; Severens JL
Hum Reprod; 2009 Jul; 24(7):1648-55. PubMed ID: 19318703
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of management strategies for obscure GI bleeding.
Gerson L; Kamal A
Gastrointest Endosc; 2008 Nov; 68(5):920-36. PubMed ID: 18407270
[TBL] [Abstract][Full Text] [Related]
20. Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance?
Das A; Wells CD; Nguyen CC
Am J Gastroenterol; 2008 Jul; 103(7):1657-62. PubMed ID: 18564119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
